The $4.88 dividend is no longer covered by the cash the business earns.

• The gap: FY2025 dividends of $1,248m exceeded reported free cash flow of $1,177m; coverage reappears only on the company's "recurring" free cash flow of $1,400m, which adds back roughly $225m a year of restructuring and strategic cash costs that recur every year.
• Time, not stress: $1,900m of cash and $2,919m of undrawn credit, with no financial-leverage covenants and a bond ladder to 2050, fund the ~$71m gap for years — even with reported free cash flow at zero, liquidity alone covers the full payout for close to four years.
• The counter, and the backstop: the $8.7bn inventory often cited as the reserve is 84.5% unreleasable aged Scotch and cognac, so this is liquidity buying time, not an inventory cash unlock — and Société Paul Ricard, collecting ~$176m of dividends a year, is structurally incentivised to defend the payout.

At about 9x banked earnings and a 7.4% yield, the price sits at the structural end of the range.

Pernod Ricard trades at ~8.8x trailing recurring earnings and a 7.4% flat-dividend yield, a price that embeds roughly 1% long-run growth against a +3% to +6% mid-term guide — the market is discounting the structural reading, and the sell-side's low target of $71.55 essentially equals the $73.13 quote. The counter sits in the same arithmetic: the 7.4% yield that underpins the floor is only thinly covered — reported free cash flow is about 95% of the payout — so a genuinely structural downshift would erode that floor rather than reward patience, and FY2027 estimate revisions are still falling.

US shipments have run below consumer sell-out for three years, a destock with a demand question underneath.

• The wedge: in FY2024 US shipments fell 9% while consumer sell-out fell only 4% and the category grew; by H1 FY2026 shipments were down 15% against a roughly flat sell-out — distributors working down inventory faster than drinkers left the shelf.
• Why it matters: a pipeline destock reverses mechanically — shipments must eventually re-converge upward to demand — which is the volume-side tailwind the cyclical case leans on for its EBITDA recovery.
• The counter: the destock has now run three years and deepened rather than healed, and Pernod's own US sell-out is only flat, not growing, so a mild demand normalisation may sit beneath the inventory story.

Gross margin held near 60% through the sales decline; the damage is operating deleverage, not lost pricing.

List-price power held through two years of falling sales: gross margin stayed within a one-point band while volumes dropped, so the ~140bps of recurring operating-margin compression is deleverage below the gross line, not shelf discounting. The change worth watching arrived in H1 FY2026, when same-brand price/mix turned negative across the core book — Absolut −3, Jameson −5, Ballantine's −5 points — and gross margin cracked to 59.3%, about a third of it tariffs. Real discounting has begun to enter what was a pure-pricing story.

India keeps growing while Martell's China channel reopens — the two pillars the recovery leans on.

• India: the only major market in organic growth every year of the downturn (+4% in H1 FY2026, +8% excluding a disposed brand), now 13% of sales, the #1 position in the world's largest whisky market with about 25m consumers reaching legal drinking age each year.
• Cognac: Martell fell 17% overall but grew 20% outside China; the China duty-free suspension from a 2024 anti-dumping case was resolved on a minimum-price undertaking, and Martell travel-retail resumed in Q2 FY2026 — global travel retail improved from −13% in FY25 to −3% in H1.
• The limit: at 13% of sales India is too small to offset the US and China falling faster, and the cognac rebound so far restored the channel, not Chinese demand (price/mix still −9%); the +3% to +6% algorithm needs the US at +3% and China flat, not India alone.

A founder family controls the vote and depends on the $4.88 dividend for income.

• Control: Société Paul Ricard, wholly owned by the founding family, held 14.29% of capital but 20.64% of votes at June 2025 and raised its stake through the downturn; with GBL, two anchors hold about 32% of votes. Double-voting rights, a 30% voting cap and change-of-control clauses make the group effectively unacquirable.
• Why the payout is defended: the family holding company's main income is its ~$176m-a-year slice of the dividend, so the controlling shareholder is structurally incentivised to hold the $4.88 — company-specific support a coverage ratio misses.
• The other edge: support is not a guarantee — it remains a payout-ratio policy, not a board-committed floor — and entrenchment means no activist or acquirer can force the issue, so any re-rating has to come through the profit-and-loss account.